SCHEMBL9628048

SCHEMBL9628048

CN(CCOc1ccc([N+](=O)[O-])cc1)CCc1ccc(NS(C)(=O)=O)cc1

nearest known ligand 0.80

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 16/20 0.80
CACNA1F O60840 1/20 0.80
CHRM2 P08172 1/20 0.80
ACHE P22303 1/20 0.80
AGTR1 P30556 1/20 0.80
DRD3 P35462 1/20 0.80
CACNA1D Q01668 1/20 0.80
CACNA1S Q13698 1/20 0.80
CACNA1C Q13936 1/20 0.80
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9630209 1.00 KCNH2 (0.80) KCNH2CACNA1FCHRM2ACHEAGTR1
Dofetilide SCHEMBL6102734 0.90 KCNH2 (1.00) KCNH2CACNA1FCHRM2ACHEAGTR1
Dofetilide SCHEMBL16135 0.90 KCNH2 (1.00) KCNH2CACNA1FCHRM2ACHEAGTR1
Dofetilide SCHEMBL8362214 0.89 KCNH2 (0.97) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL3929250 0.87 KCNH2 (1.00) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL24600680 0.84 KCNH2 (0.88) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL26239229 0.84 KCNH2 (0.88) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL9628071 0.84 KCNH2 (0.88) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL9628293 0.84 KCNH2 (0.88) KCNH2CACNA1FCHRM2ACHEAGTR1
SCHEMBL13480196 0.83 KCNH2 (0.80) KCNH2CACNA1FCHRM2ACHEAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108164429-B Preparation method of dofetilide intermediate 四川科瑞德凯华制药有限公司 2021-07-23 CN disclosed
CN-108164429-A The preparation method of Dofetilide intermediate 四川科瑞德凯华制药有限公司 2018-06-15 CN disclosed
EP-0245997-B1 N-SUBSTITUTED P-AMINOETHYLSULPHON ANILIDES AS ANTIARRHYTHMIC AGENTS, AND INTERMEDIATES THEREFOR Pfizer Limited (GB) 1992-04-15 EP disclosed
US-5079248-A Antifibrillatory agents; side effect reduction PFIZER INC. (US) 1992-01-07 US disclosed
US-4959366-A Anti-arrhythmic agents PFIZER INC. (US) 1990-09-25 US disclosed
EP-0245997-A2 N-substituted p-aminoethylsulphon anilides as antiarrhythmic agents, and intermediates therefor Pfizer Limited (GB) 1987-11-19 EP disclosed